Carol Wysham, MD

Article

Highlights in Diabetes and Metabolism From ASN 2022

Author:: Carol Wysham, MD

Publish date: November 28, 2022

From ASN 2022, Dr Carol Wysham highlights data on glucose-lowering drugs in patients with T2D, including empagliflozin and semaglutide, and a link ...

Article

Key Data on Comorbidities in Type 2 Diabetes From EASD 2022

Author:: Carol Wysham, MD

Publish date: October 6, 2022

From EASD 2022, Dr Carol Wysham reports on advancing research for patients with type 2 diabetes and comorbidities, including nonalcoholic fatty liv...